Therefore, potential systemic alteration (e.g., plasma levels of free fatty acid, TG, glucose and insulin) and other metabolic factors (e.g., body composition, adiponection) involved in hepatic steatosis should be investigated. This evidence concerns the gene INS and fatty liver disease.